granted
on 05 Mar 2024
Last Applicant/ Owned by
401 N. Broad St.
Philadelphia
PA
19108
Serial Number
97227503 filed on 19th Jan 2022
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"ASTROCYTES TO NEURONS"
Research and development of pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), Huntington's disease, epilepsy, physical injury, stroke, cerebral aneurysm, traumatic brain injury, concussion, a tumor, cancer, inflammation, infection, ataxia, brain atrophy, spinal cord atrophy, multiple sclerosis, traumatic spinal cord injury, ischemicRead More
Research and development of pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), Huntington's disease, epilepsy, physical injury, stroke, cerebral aneurysm, traumatic brain injury, concussion, a tumor, cancer, inflammation, infection, ataxia, brain atrophy, spinal cord atrophy, multiple sclerosis, traumatic spinal cord injury, ischemic or hemorrhagic myelopathy (myelopathy), global ischemia, hypoxic ischemic encephalopathy, embolism, fibrocartilage embolism myelopathy, thrombosis, nephropathy, chronic inflammatory disease, meningitis, cerebral venous sinus thrombosis, retinal disease and other disease arising from neuronal damage; and testing, inspection, research or development of pharmaceutical preparations for gene therapy or small molecule treatment
No 97227503
No Service Mark
No 4736/2005
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 06th Mar 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 05th Mar 2024 | SOU TEAS EXTENSION RECEIVED |
| 05th Mar 2024 | SOU EXTENSION 2 FILED |
| 05th Mar 2024 | SOU EXTENSION 2 GRANTED |
| 28th Jul 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 26th Jul 2023 | SOU TEAS EXTENSION RECEIVED |
| 26th Jul 2023 | SOU EXTENSION 1 FILED |
| 26th Jul 2023 | SOU EXTENSION 1 GRANTED |
| 11th Apr 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 14th Feb 2023 | PUBLISHED FOR OPPOSITION |
